NCT05022446 The Impact of COVID-19 on Pulmonary Procedures
| NCT ID | NCT05022446 |
| Status | Recruiting |
| Phase | — |
| Sponsor | M.D. Anderson Cancer Center |
| Condition | COVID-19 Infection |
| Study Type | OBSERVATIONAL |
| Enrollment | 250 participants |
| Start Date | 2020-11-11 |
| Primary Completion | 2027-02-02 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 250 participants in total. It began in 2020-11-11 with a primary completion date of 2027-02-02.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study investigates the changes in practice by pulmonary procedural programs across the United States as they faced the coronavirus pandemic. Information gathered from this study may help guide pulmonary programs on a wider scale and improve their practice. The study may also help researchers understand where they should focus research efforts to better respond to a pandemic in the future.
Eligibility Criteria
Inclusion Criteria: * Pulmonologists that are members of the American Association of Bronchology and Interventional Pulmonology (AABIP) and/or the American College of Chest Physicians (ACCP) * These organizations were chosen because their member databases are composed of pulmonologists in the United States (U.S.) that perform the pulmonary procedures described in this survey. Letters of approval will be obtained from these organizations and provided to the MD Anderson Institutional Review Board (IRB). Once the MD Anderson IRB approves this survey study, the survey will be sent to the relevant subcommittees of these organizations for their electronic dissemination to their membership Exclusion Criteria: None
Contact & Investigator
Bruce F Sabath, MD
PRINCIPAL INVESTIGATOR
M.D. Anderson Cancer Center
Frequently Asked Questions
Who can join the NCT05022446 clinical trial?
This trial is open to participants of all sexes, studying COVID-19 Infection. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05022446 currently recruiting?
Yes, NCT05022446 is actively recruiting participants. Contact the research team at jzaveri@mdanderson.org for enrollment information.
Where is the NCT05022446 trial being conducted?
This trial is being conducted at Houston, United States.
Who is sponsoring the NCT05022446 clinical trial?
NCT05022446 is sponsored by M.D. Anderson Cancer Center. The principal investigator is Bruce F Sabath, MD at M.D. Anderson Cancer Center. The trial plans to enroll 250 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.